SGLT2 Inhibitors: From Antihyperglycemic Agents to All-Around Heart Failure Therapy

Post time 2022-7-29 23:02:43

journal：Circulation

Authors：Stefan D. Anker; Muhammad Shariq Usman; Javed Butler

Published date：2022-7-26

DOI：10.1161/circulationaha.122.060348

Article link：http://dx.doi.org/10.1161/circulationaha.122.060348

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 2022-7-29 23:02:44

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AHA] SGLT2 Inhibitors: From Antihyperglycemic Agents to All-Around Heart Failure Therapy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] SGLT2 Inhibitors: From Antihyperglycemic Agents to All-Around Heart Failure Therapy Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] SGLT2 Inhibitors: From Antihyperglycemic Agents to All-Around Heart Failure Therapy